BBVA

Stronger trading gains and accelerated cost of risk normalisation

30/04/21 -"The quarter was marked by the deconsolidation of the US operations, albeit the accretive impact on the capital position still has to be factored in. It enjoyed strong CIB revenues and accelerated ..."

PDF page sample
Pages
59
Language
English
Published on
30/04/21
Download
You may also be interested by these reports :
19/11/25
Credit Agricole unveiled an ambitious 2025-28 plan targeting >14% ROTE and >€8.5bn net income, implying 14–16% RoCET1 depending on the use of its ...
17/11/25
As its name suggests, Swiss Life (REDUCE ; Switzerland) focuses on pensions and savings – it is in fact one of the few pure (or almost pure) plays in ...
14/11/25
Two months ago, we looked at Investor performance under Trump II. Since Trump’s election, Industrivärden (ADD; Sweden) has followed a very similar ...
13/11/25
KBC delivered another quarter of accelerating earnings momentum, with upgrades to 2025 guidance supported by broad-based growth, strict cost control, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO